3597166
doi
10.5281/zenodo.3597166
oai:zenodo.org:3597166
user-iajpr
NANOPARTICLES - THE FUTURE OF DRUG DELIVERY
Arjun Sai Sreekar Aeila*, Tirandi.Manohara Sai, A.Rohit Kumar
GITAM Institute of Pharmacy, GITAM (Deemed To Be University) Rushikonda, Visakhapatnam, 530045, Andhra Pradesh, India.
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
Nanomaterials, Liposomes, Dendrimers, Nanocrystal.
<p>There has been considerable interest in drug delivery research over the past few decades using Particulate delivery systems as carriers of small and large molecules. Particulate structures such as nanoparticles have been used as a physical tool to modify and improve the pharmacokinetic and pharmacodynamic properties of different types of drug molecules. They were used <em>in-vivo</em> to Protect the drug entity in the systemic circulation, restrict the drug's access to the selected locations, and deliver the drug to the site of action at a controlled and sustained rate. Different carriers have been used to increase therapeutic benefit in the formulation of nanoparticles for drug delivery research, while minimizing side effects. Here we review different aspects of the formulation of nanoparticles, their characterization, their effects and their applications in the delivery of drug molecules.</p>
Zenodo
2020-01-03
info:eu-repo/semantics/article
3597165
user-iajpr
1579536339.956015
545728
md5:d16d0775fca058f8cd1a856070cfa547
https://zenodo.org/records/3597166/files/191202.pdf
public
10.5281/zenodo.3597165
isVersionOf
doi